decorative background image

Influencing Policy

PBGH is committed to containing unrelenting annual health care cost increases that impose an intolerable financial burden on patients and limit employers’ ability to grow and compete globally.

Our policy initiatives are grounded in a commitment to market-based solutions that encourage healthy competition among providers, health plans, drug manufacturers and suppliers. Where health care sectors are impervious to traditional market forces due to a lack of competition and entrenched monopoly power, we support legislative and legal action to restore affordability, quality and equity.

 

Policy Work


COVID-19

PBGH advocates for sufficient public health resources to fight the pandemic, economic supports to help the country weather the resulting economic downturn.

Read More about COVID-19

Reducing Drug Prices

PBGH works with policymakers and stakeholders to inject more competition, transparency and value into the health care system.

Read More about Reducing Drug Prices

Tackling High Costs

PBGH seeks to uproot the economic distortions in the nation’s health care payment and delivery system to ensure that health care is affordable and accessible to everyone in the country.

Read More about Tackling High Costs

Fair Health Costs Initiative

The Fair Health Costs Initiative is an effort by PBGH and National Alliance of Healthcare Coalitions to mobilize employer purchasers, educate policymakers and advocate for public policies to reduce health care prices.

Read More about Fair Health Costs Initiative

Payment Reform and Quality Improvement

PBGH works with policymakers to advance the development and application of alternative payment models that hold providers accountable for quality of care.

Read More about Payment Reform and Quality Improvement

Health Equity

PBGH is committed to identifying and championing health policies that ensure health equity for all people in our country.

Read More about Health Equity

The Future of Health Coverage Employer-Sponsored Insurance Policy

PBGH is actively engaged in promoting solutions that both increase access to health care coverage while driving down costs for all purchasers of health care.

Read More about The Future of Health Coverage Employer-Sponsored Insurance Policy

Tackling Market Consolidation

Anticompetitive practices that stifle employers’ ability to negotiate for the best health care value for their workers has become a growing concern.

Read More about Tackling Market Consolidation

Resources

Response to HHS RFI about Primary Health Care

PBGH Response to the RFI on Federal Merger Guidelines

Many experts have pointed to anticompetitive conduct and industry consolidation as a driver of high health care costs.

PBGH Letter of Support for California AB 2080 (Wood)

PBGH submitted a letter of support for AB 2080 (Wood) which would prohibit anti-competitive contracting provisions.

PBGH Letter of Support for California SB 1033

PBGH submitted a letter of support for California SB 1033 which would address health disparities, improve health care quality and outcomes and address overall population health.

PBGH Letter on Pharmacy Cost Transparency Interim Final Rule

PBGH continues to advance pharmacy cost transparency on behalf of purchasers through standardized reporting requirements.

Joint Employer Letter on No Surprises Act Interim Final Rule

Organizations representing many of the nation’s largest employers and health care purchasers issued a letter regarding CMS-2021-0156, the second interim final rule (IFR), implementing the No Surprises Act, banning surprise medical billing.

California Coalition Letter on No Surprises Act Interim Final Rule

The No Surprises Act will help accelerate our efforts to protect consumers, improve the quality and affordability of their care, and address the longstanding market failures that contributed to a nationwide affordability crisis.

EmployersRx Letter to House Leaders on HR 3

EmployersRx sent a letter to House leaders expressing support for H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, and urging that all price protections included should be extended to Americans covered by commercial insurance.

Employer Groups Send Letter on Drug Pricing to Senate Committee of Finance Chairman

Employer groups have sent a letter to Senate Committee on Finance Chairman Sen. Ron Wyden to urge him to protect all Americans from ever-rising prescription drug prices.

Letter Urging Federal Agencies to Protect Patients with Surprise Billing Rule

PBGH joined nearly 60 consumer and employer organizations urging that surprise billing loopholes be closed in the administration’s looming rule.

Comment Bubble

PBGH Letter on the 2022 Medicare Inpatient Perspective System (IPPS) Rule

Letter to the White House on Health Care Costs

PBGH statement to the House Judiciary Subcommittee on Antitrust, Commercial and Administrative – 4/29/21

Letter to California Assembly Health Committee Re: Office of Health Care Affordability (AB 1130)

Testimony: California’s Office of Health Care Affordability (AB 1130)

Elizabeth Mitchell – Testimony to Senate HELP Committee 6/18/19

General COVID Resources